Latest Articles
‘Going Through a Lot’- Danielle Collins’ Retirement U-Turn Dissected With Empathy Ahead of Her 2025 WTA Comeback - MSN
‘Going Through a Lot’- Danielle Collins’ Retirement U-Turn Dissected With Empathy Ahead of Her 2025 WTA Comeback MSN
Published: Dec. 4, 2024, 6:03 p.m.
Grad students pitch impactful ideas to drive real change - Brighter World
Grad students pitch impactful ideas to drive real change Brighter World
Published: Dec. 4, 2024, 5:34 p.m.
Characteristics and Infertility Association in Women with Endometriosis - Physician's Weekly
Characteristics and Infertility Association in Women with Endometriosis Physician's Weekly
Published: Dec. 4, 2024, 1:07 p.m.
Essex teen says endometriosis shouldn't be 'taboo' as she shares her story - Clacton and Frinton Gazette
Essex teen says endometriosis shouldn't be 'taboo' as she shares her story Clacton and Frinton Gazette
Published: Dec. 4, 2024, 9:01 a.m.
What is Visanne, the endometriosis drug just added to the PBS? - New Zealand Doctor Online
What is Visanne, the endometriosis drug just added to the PBS? New Zealand Doctor Online
Published: Dec. 4, 2024, 1:33 a.m.
Woman's Doctor: Know the symptoms of endometrial cancer - MSN
Woman's Doctor: Know the symptoms of endometrial cancer MSN
Published: Dec. 3, 2024, 8:37 p.m.
Elagolix with add-back therapy found effective and tolerable for endometriosis pain - Contemporary Obgyn
Elagolix with add-back therapy found effective and tolerable for endometriosis pain Contemporary Obgyn
Published: Dec. 3, 2024, 6:36 p.m.
Condition affecting millions linked with premature death and cancer risks - Express
Condition affecting millions linked with premature death and cancer risks Express
Published: Dec. 3, 2024, 12:58 p.m.
Woman Shocked To Wake Up From Routine Surgery To Find Doctors Removed An Extra Organ - Wide Open Country
Woman Shocked To Wake Up From Routine Surgery To Find Doctors Removed An Extra Organ Wide Open Country
Published: Dec. 3, 2024, 11:04 a.m.
HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer - GlobeNewswire
HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer GlobeNewswire
Published: Dec. 3, 2024, 10:01 a.m.
Link copied to clipboard!